chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had the vaccine and during the 15 minutes wait on the chair, she felt dizzy and felt on the floor. Patient is alert and communicating  the whole time. Called 911 and paramedic came and took her to hospital since she felt and hit her head on the floor.
This case was reported by a healthcare professional and described the occurrence of seizures in a female child subject (who was 17 years old at the time of reporting) who was vaccinated with Dtap for prophylaxis. On an unknown date during the subject's childhood, she received unspecified dose(s) of DTAP vaccine. At an unspecified time after vaccination with DTAP, the subject experienced seizures. This case was assessed as medically serious by manufacturer. At the time of reporting, the outcome of the event was unspecified. Of note, the report from the manufacture noted that the adverse event descriptions cited "only a history of seizures after receiving DTAP as a child." No further information was available.
Information has been received from a physician (OB/GYN) concerning a 21 year old female patient who on an unspecified date was vaccinated with her first dose of GARDASIL (lot number, site and route not reported) at her pediatrician's office and then a short time after she was diagnosed with the shingles. The physician reported that the patient's pediatrician thought she developed the shingles due to GARDASIL and so the patient did not received the rest of the series. The patient sought medical attention in the pediatrician's office. Additional information has been requested.
FEVER OVER 100, SEVERE HEADACHE,  BODY ACHES, CHILLS, RIGORS, SHARP PAINS, CAUSED MY NERVE PAIN FROM THE STROKE TO BE VERY BAD, TINGLING ON MY AFFECTED SIDE, NAUSEA, DIZZINESS, DEHYDRATION, FATIGUE. I WAS GIVEN TYLENOL, IBUPROFEN, ZOFRAN, ATIVAN, AND 2 BAGS OF FLUIDS.
24 hours after the vaccine was administered, patient developed a low grade fever and sore arm.  She took Advil.  At 3:30 pm she spiked a fever and had chills.  6:30 pm her heart was racing, temp 103.5.  She called her MD on call.  He recommended Benadryl (patient did not have any) and cold compresses.  8:30 pm Temp 102.  11-11-11 2 Am Had chills and temp 102.  Took Tylenol.  Woke in am with achiness and continued painful right arm.  Temp now gone but arm painful with resistence.  She said the arm does not have redness or swelling but there is a bruise.  She said it does not appear infected.  I recommended she follow up with her provider if the arm does not improve and could try warm compresses or ice (which ever felt better to her to help decrease the pain.  On a scale of 1-10, at it's worst the pain was a 7 and now is a 2.
A coin sticks to my arm like a magnet; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Aug2021 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 infection (prior to the vaccination, the patient was diagnosed with COVID-19). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient did not have allergies to medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 01Sep2021, the patient reported that a coin sticks to her arm like a magnet. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event a coin sticks to arm like a magnet was recovering at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
12-01-2021- Patient received second Pfizer-COV (5-11) Immz, 0.2 mls/ IM. (parent had forgotten to bring COV-Card from first Immz). This was given in Error on Day 15, post first COV-Immz Date (11/16/2021). As soon as error was discovered -while patient & father were still in office; Dr was alerted & RN,; who began investigating for proper protocol steps.  Dr spoke with father in exam room and then again by phone, providing all COV-Immz.-Information with Recommendations. Father stated he will discuss with Mother and call back with their decision concerning another Immz. Patient had no immediate s/s of any  adverse reaction, when leaving office. Proper Error Reports /VAERS & Incident Report will be completed by RN & reviewed by initial RN. A new plan was put in place to prevent this error in the future, with several "double checks & confirmations".  12-02-2021- Follow Up call has been placed to parent of pt.; Mother reports; pt is doing well, no s/s of adverse reactions. Asked Mom to call back if anything changes, mom voiced understanding.
Dose 1 - Severe headache, body aches to include extremely stiff neck, rash on arms, upper chest, belly and thighs, extreme fatigue and low grade fever lasting 2 days.  Dose 2 - Severe headache for 5 days. Full body pain, extremely stiff neck - unable to turn head left or right, knee, hip and ankle joint pain whenever I would walk, rash on arms, upper chest, belly and thighs, extremely emotional and extreme fatigue - all lasting a little over 2 weeks. Had a fever of (100.2 - 102.0) for 5 straight days after vaccine administration. Missed 3 days, after receiving of work due to fever and extreme fatigue.
Pain at injection site had lasted for 3 weeks. Extreme pain in deltoid where injection was when reaching left arm across body. Shoulder pain and impingement when raising my arm.  Pain and inflammation in shoulder, rotator cuff area. Pain so bad that unable to sleep on left arm, raise my arm, pain doing movements like taking off my shirt. Was prescribed oral steroids to treat inflammation, along with heat, rest, and topical steroid. Will assess pain after steroid treatment to see if physical therapy or any other treatment needed.
This spontaneous report was received from medical assistant refers to an unspecified patient of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On 11-MAR-2016, patient was inadvertently administered with ROTATEQ suspension 2, that had been improperly stored, lot # L037921 (expiry date: 31-MAY-2017), orally (dosage not reported). The vaccine was stored at a temperature 30.2F and time frame included cumulative time of 132 hours. No previous temperature excursion was reported. No adverse effects reported. No product quality complaint (PQC) involved. No further information provided. This is one of several reports received from the same reporter. Additional information has been requested.
Day 0-2 - left deltoid soreness, vague malaise Day 4 - unexplained anger Day 6-7 - bilateral quadriceps soreness, headache --- No treatment sought for any of the above.  Patient took acetaminophen for headache
A little Achy After the first Monovalent booster; First Monovalent booster dose was given on 23DEC2021 and 2nd dose was given on 05MAY2021; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (A little Achy After the first Monovalent booster) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Monovalent booster dose was given on 23DEC2021 and 2nd dose was given on 05MAY2021) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059H21A, 027C21A and 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Crohn's disease (Crohn's Disease for the past 2 years.) and Immunocompromised.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Dec-2021, the patient experienced PAIN (A little Achy After the first Monovalent booster) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Monovalent booster dose was given on 23DEC2021 and 2nd dose was given on 05MAY2021). At the time of the report, PAIN (A little Achy After the first Monovalent booster) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Monovalent booster dose was given on 23DEC2021 and 2nd dose was given on 05MAY2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had Crohn's Disease, It was under control prior to receiving the Moderna COVID-19 Vaccine. No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2022-677400, MOD-2022-677451 (Patient Link).
pt fainted became unresponsive for approx 1min then became conscious started coughing-911 called;
After my 2nd dose of Pfizer I experienced severe itching and blistering all over my entire body.
Information has been received from a physician concerning an 18 year old male student, who as a child, was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). It was reported that on 05JUNE2003 laboratory tests showed that the patient tested positive for rubella (50, positive for rubeola (1.23), and negative for mumps. It was noted that the patient would be revaccinated. No further information was available. Unspecified medical attention was sought. Additional information has been requested.
Episode of becoming limp and unresponsive lasting approximately 25 minutes. Occurred after feed. No jerking or posturing. Normal O2 sat and blood glucose. Taken to Hospital by ambulance and was responsive there on arrival.  Infant had no fever and was otherwise well. Normal exam. Has referral to neurology.
Information has been received from a medical assistant concerning a male patient who in 2004 was vaccinated with his first dose of PNEUMOVAX 23, and on 30-AUG-2009 he received a second 0.5ml dose (lot # 662840/1577X) SC in the right deltoid. The patient's relevant medical history and relevant past drug history were unknown. On 30-AUG-2009, after the vaccination, the patient had redness, hives and itching with local traveling at injection site. It was unknown if a similar reaction occurred with the 2004 administration of PNEUMOVAX 23. It was unknown if any lab tests were performed. As of 30-AUG-2009, it was unknown if the patient would receive another dose of PNEUMOVAX 23. The patient was currently in with the doctor receiving medical attention and the outcome of the events was unknown. Additional information has been requested.
Pt diagnosed with chickenpox by ECU physician at hospital and medical center on 10/1/04. Had Varicella vaccine on 10/19/2000
Initial information received on 26 August 2014 from a consumer who is the patient's parent. A 17 year old female patient was vaccinated on 18 August 2014 into the deltoids with the following vaccines: MENACTRA (batch number, route and site of administration were not reported) and HPV vaccine (other manufacturer; batch, route and site of administration not reported). The patient was feeling well on the day of vaccination and had no pre-existing physician diagnosed allergies or medical conditions. On 19 August 2014, she developed a fever and severe low back pain near her coccyx. The patient is unable to walk. The mother took her to the emergency room this week and she had multiple tests. Mostly recently, "yesterday", she had a CT of the abdomen and pelvis which were all negative. Other lab tests were reported as Mono spot, Lymes, CBC, all Negative. "Lots of other blood work". A low spinal xray is pending. The mother is very concerned as her daughter is due to go to college next week. The fever and pain are continuing. The patient outcome is not recovered. Documents held by sender: None.
12 days post vaccine my left arm became swollen and red around the injection site (about two inches around).
On 2/19/21 @ 11PM he was fine and had been talking laughing and playing his trumpet right up until bedtime Less than 2 hours later his wife was alarmed to hear him struggling to breathe When he tried to urinate he could only pass blood She called 911 @01:00 AM 02/20/2021 They administered oxygen and transported him to ED {this form won't let me fill in any of the shaded boxes} EMS said his lungs sounded like he had pneumonia  Extensive testing focused on his lungs and kidneys as the source of infection and inflammation Please note that no source could be found! He was discharged home with strong steroids and antibiotics and instructed to use a inhaler 4x a day on 02/25/2021 5 days
Patient has a cold; Congestion; The injection site is magnetized, I can stick a magnet to the injection site; Injection site is the size of a dime; Injection site is red; Injection site is swollen; Headache; Patient is 31 weeks pregnant; Injection site left arm was sore.; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Patient has a cold), NASAL CONGESTION (Congestion), VACCINATION SITE REACTION (The injection site is magnetized, I can stick a magnet to the injection site), VACCINATION SITE PAPULE (Injection site is the size of a dime) and EXPOSURE DURING PREGNANCY (Patient is 31 weeks pregnant) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-Jan-2021 and the estimated date of delivery was 28-Oct-2021. On 18-Aug-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient is 31 weeks pregnant) and VACCINATION SITE PAIN (Injection site left arm was sore.). On 26-Aug-2021, the patient experienced NASOPHARYNGITIS (Patient has a cold), NASAL CONGESTION (Congestion), VACCINATION SITE REACTION (The injection site is magnetized, I can stick a magnet to the injection site), VACCINATION SITE PAPULE (Injection site is the size of a dime), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site is swollen) and HEADACHE (Headache). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy.  On 18-Aug-2021, EXPOSURE DURING PREGNANCY (Patient is 31 weeks pregnant) had resolved. At the time of the report, NASOPHARYNGITIS (Patient has a cold), NASAL CONGESTION (Congestion), VACCINATION SITE REACTION (The injection site is magnetized, I can stick a magnet to the injection site), VACCINATION SITE PAPULE (Injection site is the size of a dime), VACCINATION SITE PAIN (Injection site left arm was sore.), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site is swollen) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient stated that she is 31 weeks pregnant currently, with a due date of 28 October 2021.  No concomitant product use was provided by the reporter.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Significant follow-up. Pregnancy details updated. New event-vaccination exposure during pregnancy added.; Sender's Comments: This is a case of product exposure during pregnancy with associated AEs for this 3 5-year old female. Patient will not be contacted for further monitoring of AEs during the pregnancy.
Patient presents to hospital with c/o nausea and some vomiting; tested positive for COVID-19 2 days prior to admission; O2 SATS 80% on RA; O2 supplement of 2L via NC; given MVI, Vitamins C and D, zinc; does not qualify for antiviral or plasma therapy; given Decadron; AKI on chronic kidney disease; COVID bilateral pneumonia; increase in O2 demand, placed on BiPAP; transferred to ICU; patient experienced respiratory distress, required intubation with mechanical ventilation; family opted for comfort care measures; patient was extubated and he died in the hospital.
Medication error. Received Moderna vaccine 12/31/20 as first dose. Received Pfizer vaccine 1/29/2021 as second dose.
20 minutes after dose pt experienced some chest tightness, trouble breathing, and headache. Patient was still talking so gave her 50mg Benadryl and ice water, had her sit down and continue drinking water for another 30 minutes. 30 minutes after Benadryl was given patient's symptoms subsided.
Burning sensation on skin - in particular on forehead, ears, and neck (felt like a sun-burn - temperature was raised and inflamed); Burning sensation on skin - in particular on forehead, ears, and neck (felt like a sun-burn - temperature was raised and inflamed); Burning sensation on skin - in particular on forehead, ears, and neck (felt like a sun-burn - temperature was raised and inflamed); This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 19Apr2021 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included eczema, asthma, sulfonamide allergy, penicillin allergy and shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included fluticasone propionate, salmeterol xinafoate (WIXELA INHUB) for unknown indication on unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 29Mar2021 at 15:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 12:00, the patient experienced burning sensation on skin - in particular on forehead, ears, and neck; felt like a sun-burn - temperature was raised and inflamed. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event burning sensation on skin - in particular on forehead, ears, and neck; felt like a sun-burn - temperature was raised and inflamed was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
swelling underneath her armpit the same side she had the vaccine which is the right arm; swelling is the size of a large egg or small avocado and when she touches it, it's soft and it hurts; booster; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 57-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), third dose via an unspecified route of administration, administered in Arm Right on 09Nov2021 17:45 (at the age of 57 year) as DOSE 3 (BOOSTER DOSE), SINGLE for covid-19 immunization. The patient medical history and concomitant medications. Patient did not go Emergency Room or Physician Office. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), second dose via an unspecified route of administration, administered on unspecified date as DOSE 2, SINGLE and bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), second dose via an unspecified route of administration, administered on unspecified date as DOSE 1, SINGLE both for covid-19 immunization. Patient did not took Prior Vaccinations (within 4 weeks). The patient had booster dose on 09Nov2021 and on 11Nov2021 patient experienced swelling underneath her armpit the same side she had the vaccine which is the right arm and swelling is the size of a large egg or small avocado and when she touches it, it's soft and it hurts. The outcome of the events was not recovered.  The lot number for the vaccine, [bnt162b2], was not provided and will be requested during follow up.
Patient entered hospital 6/20 complaining of chest pain. Diagnosed with pulmonary embolism. Patient died 6/28.
Patient c/o being "hot and sweaty" and lightheaded, 30-60 mins. after flu shot. No other symptoms presented. BENADRYL 50 mg p.o. given per M.D.'s order. DX - mild allergic reaction from Influenza vaccine.
Breakthrough case admission after 4 vaccines Moderna 2/4/21 Lot# 013M20A;  Moderna 3/4/21 Lot# 030A21A;  Moderan 11/19/21 Lot# 034F21A;  4/15/22 Moderan Lot# 005M21A
lt arm swollen from deltoid to 2-3cm below elbow;erythema over triceps=5x10cm;sl tender;inj site in upper arm;pt has hx of cellulitis;began improving p/4 days;
I got my 2nd dose in the left arm,. About 35 hours later the lymph node on the left side of my collar bone has become painfully inflamed. Then the lymph node on the inside of my left arm has also become painfully inflamed. The injection site of my first shot on the opposite arm has also become sore.
Sever head pain, chest tightness, difficulty breathing, naseau, vomiting, passing out, uncontrollable hand/arm shaking (not arm of injection) for hours-- had to be rushed to the ER; I remained ill for 2 full weeks following the injection
JOINT PAIN ALL OVER (KNEE, SHOULDER, ARMS AND ELBOWS); This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, non-smoker, penicillin allergy, and shell fish allergy, and other pre-existing medical conditions included: The patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, and expiry: 11-APR-2022) dose was not reported, administered on 06-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-DEC-2021, the patient experienced joint pain all over (knee, shoulder, arms and elbows). Laboratory data (dates unspecified) included: Blood test (NR: not provided) RA factor more than 250. Treatment medications (dates unspecified) included: celecoxib. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from joint pain all over (knee, shoulder, arms and elbows). This report was non-serious.
Purple welt rash  on legs 2 days - 5 days after vaccine, low grade fever about 100-101 degrees F 5-7 days after vaccine. Macular/papular rash 1 week after vaccine.
Initial report from a health care professional on 10 May 2010: The patients were vaccinated with MENVEO, intramuscularly, on 10 May 2010. The  reporter stated that the vaccine was, unreconstituted and was left out at room temperature for up to 16 hrs. No further information was provided. Follow-up report received from a health care professional (medical assistant) on 26 May 2010: This child was vaccinated with MENVEO (batch no: 100003), (dose: unknown) on 10 May 2010. The reporter stated that, the vaccine that was administered was not refrigerated and it was at room temperature for 16 hours. The child had no reaction following this administration.